Success and safety of high infliximab trough levels in inflammatory bowel disease
David Drobne, A. Smid(University of Ljubljana), Polona Rajar(Ljubljana University Medical Centre), Luka Strniša(University of Ljubljana), Ivan Ferkolj(University of Ljubljana), Matic Koželj(Ljubljana University Medical Centre), Samo Plut(University of Ljubljana), Nataša Smrekar(Ljubljana University Medical Centre), Tina Kurent(Ljubljana University Medical Centre), Polona Švegl(Ljubljana University Medical Centre), Borut Štabuc(University of Ljubljana), Jernej Brecelj(University of Ljubljana), Saša Golob(Ljubljana University Medical Centre), Nejc Sever(Ljubljana University Medical Centre), Rok Orel(Ljubljana University Medical Centre), Jurij Hanžel, Matjaž Homan(University of Ljubljana), Sara Terzić(Ljubljana University Medical Centre), Darja Urlep(Ljubljana University Medical Centre), Joško Osredkar(Ljubljana University Medical Centre), Gregor Novak(University of Ljubljana)
Cited by 46
Related Papers
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Joint ESPGHAN/NASPGHAN Guidelines for the Management of <i>Helicobacter pylori</i> in Children and Adolescents (Update 2016)
|Journal of Pediatric Gastroenterology and Nutrition|2017|467
Paediatric Gastrointestinal Endoscopy
|Journal of Pediatric Gastroenterology and Nutrition|2016|274